Evidence mapPaperPMID 41810356Full record

ArticleRisk management and healthcare policy2026

Evaluating the Impact of National Essential Public Health Services Program Coverage on Hypertension Management, Medical Care Utilization and Household Socioeconomic Well-Being.

Yuheng Luo, Zhong Cao, Pascal Geldsetzer, Qiushi Chen, Zhuang Hao, Liu He, Till Bärnighausen, Chen Wang, Simiao Chen

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuheng Luo *School of Health Policy and Management, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.ORCID 0009-0009-2592-9290
Zhong Cao *Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Pascal GeldsetzerDivision of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Qiushi ChenHarold and Inge Marcus Department of Industrial and Manufacturing Engineering, The Pennsylvania State University, University Park, PA, USA.
Zhuang HaoSchool of Economics and Management, Beihang University, Beijing, People's Republic of China.ORCID 0000-0001-5027-3574
Liu HeSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.ORCID 0000-0002-4930-3673
Till BärnighausenHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Chen WangSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
Simiao ChenHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Launched in 2009, China's National Essential Public Health Services Program (NEPHSP) has been broadly implemented throughout the country. However, rigorous evaluations of its impact on chronic disease outcomes remain limited. Hypertension, being one of the major noncommunicable diseases targeted by the program, provides an important case study for assessing its effectiveness. Methods: We used longitudinal data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018 to evaluate the impact of receiving NEPHSP-covered services (from 2015 onward) on hypertension management. A difference-in-difference approach with two-way fixed effects was used on a cohort of 774 hypertensive adults to estimate changes in health and socioeconomic outcomes associated with NEPHSP coverage. Results: NEPHSP participation contributed to significant increases in hypertension control (9.8%; 95% CI: 2.7-16.9%; p<0.01) and treatment rates (9.9%; 95% CI: 3.8-16.1%; p<0.01). It also increased inpatient admissions by 0.17 per year (95% CI: 0.03-0.31; p<0.05). No significant effect was found on outpatient visits. In addition to clinical benefits, involvement in NEPHSP was linked to a 5.4% reduction in the Engel coefficient (95% CI: 1.2-9.6%; p<0.05), indicating improved household economic well-being. These impacts were more pronounced among younger adults and urban residents, highlighting disparities across subpopulations. Conclusion: The findings provide evidence that NEPHSP has improved hypertension management and household economic well-being. To further maximize these gains, future policy refinements should focus on adapting services to the specific needs of older age groups and other less-responsive subpopulations to ensure universal health equity.

Indexed as

difference-in-difference analysisessential public health servicehealth policy evaluationhypertension management

Identifiers

PMID41810356
PMCPMC12968561

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.